U.S. Overactive Bladder Market

U.S. Overactive Bladder Market published by Frost & Sullivan in November, 2009. This report consists of 83 Pages and the price starts from US $ 6000.

Introduction

This research service covers the U.S. overactive bladder market from 2005-2015. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, patient forecasts and market share analysis. The market is segmented by product: Detrol, Detrol LA, Ditropan, Ditropan XL, Enablex, Oxytrol, Sanctura, Sanctura XR, VESIcare, and others. Major market challenges, drivers, and restraints and identified and discussed as well as pipeline by phase.

1. Executive Summary

U.S. Overactive Bladder Market

• Introduction

2. Market Introduction

Research Scope and Methodology

• Scope and Segmentation
• Research Methodology

Market Overview

• Market Engineering Measurements
• Disease Overview
• Treatment Options
• Patient Forecasts
• Industry Challenges
• Market Drivers
• Market Restraints

Product Analysis

• Product Analysis
• Product Comparisons
• Recently Approved Products

Pipeline Analysis

• Phase III
• Phase II
• Phase I

3. Competitive Analysis

Overview

• Competitive Structure

Forecasts and Trends

• Total Market
• Revenue Forecasts by Product

Market Share Analysis

• Company Market Share
• Product Market Share
• Drug Delivery Market Share

4. Appendix

Decision Support Databases

• Population 65 Plus
• Female Population 65 Plus
• Male Population 65 Plus
• Total Life Expectancy at Birth
• Birth Rate

Related Reports